Chesnara Plc: Fourth acquisition in two years
12 November 2026
U.S. Physical Therapy, Inc. (NYSE: USPH) is gaining traction among investors, buoyed by a promising 40.71% potential upside according to analyst consensus. This Houston-based company, specializing..
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotechnology firm focused on autoimmune diseases, presents a compelling opportunity for investors with its innovative therapies and promising financial..
Evolent Health, Inc (NYSE: EVH) stands as a key player in the health information services industry, offering an integrated platform for health plan administration and value-based..
Phreesia, Inc. (NYSE: PHR) is garnering the attention of investors with its promising 18.74% potential upside, according to analyst ratings. As a key player in the..
AtriCure, Inc. (NASDAQ: ATRC), a leading player in the healthcare sector, specializes in the development and sale of advanced medical devices for cardiac surgery. With a..
For investors exploring opportunities in the biotechnology sector, Viridian Therapeutics, Inc. (NASDAQ: VRDN) presents an intriguing prospect. With a market cap of $1.41 billion, this U.S.-based..
For investors with an appetite for high-risk, high-reward opportunities, Biohaven Ltd. (NASDAQ: BHVN) presents a compelling case. The biotechnology company, headquartered in New Haven, Connecticut, is..
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents a compelling case for..
Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, has garnered significant attention from investors, particularly due to its potential upside of over..
Progyny, Inc. (NASDAQ: PGNY) stands as a beacon of innovation within the healthcare sector, particularly in the niche of fertility and women’s health benefits. Headquartered in..
For investors with an eye on the biotechnology sector, Centessa Pharmaceuticals plc (NASDAQ: CNTA) presents an intriguing opportunity. Headquartered in Altrincham, United Kingdom, Centessa is a..
For investors looking to explore opportunities within the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents a compelling case. With a focus on home health,..
For investors seeking opportunities in the healthcare sector, Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents a potentially intriguing option, offering a glimpse into the world of..
Mineralys Therapeutics, Inc. (MLYS) is emerging as a noteworthy player in the biotechnology sector, with a particular focus on addressing diseases driven by dysregulated aldosterone. This..
Innoviva, Inc. (NASDAQ: INVA) is gaining attention in the biotech industry for its promising growth prospects and strategic partnerships, despite recording a recent dip in its..
For investors with an eye on the healthcare sector, agilon health, inc. (AGL) presents a fascinating, albeit complex, opportunity. With a current market cap of $823.76..
Evotec SE (EVO), with its roots deeply embedded in Germany’s healthcare sector, has emerged as a significant player in the drug discovery and development landscape. The..
Mesoblast Limited (NASDAQ: MESO), a pioneering firm in the biotechnology sector, is capturing investor attention with a potential upside of 69.49% based on analyst target price..
Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a key player in the healthcare sector, is carving out a significant niche with its diversified home care platform in..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has captured investor attention with its promising strides in the biopharmaceutical landscape, particularly in developing therapies for rare and debilitating diseases...
